STOCK TITAN

Novan, Inc. to Present at Two Upcoming Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

DURHAM, N.C., March 14, 2022 (GLOBE NEWSWIRE) -- Novan, Inc. (Nasdaq: NOVN) announced that CEO Paula Brown Stafford will present at two investor conferences. The 34th Annual Roth Conference will feature a fireside chat on March 14, 2022, at 3:30 PM ET. The Oppenheimer 32nd Annual Healthcare Conference will have a virtual presentation on March 16, 2022, at 1:20 PM ET. A webcast for both events will be available on Novan's website for 90 days post-event. Novan specializes in dermatology, focusing on innovative therapies for skin diseases.

Positive
  • None.
Negative
  • None.

DURHAM, N.C., March 14, 2022 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that Paula Brown Stafford, President and Chief Executive Officer of Novan, will be presenting at two upcoming investor conferences.

The details for the upcoming conferences are as follows:

34th Annual Roth Conference

  • Event: Fireside Chat and Q&A
  • Date and Time: Monday, March 14, 2022, at 3:30 PM ET

Oppenheimer 32nd Annual Healthcare Conference

  • Event: Virtual Presentation
  • Date and Time: Wednesday, March 16, 2022, at 1:20 PM ET

A webcast of the fireside chat and presentation will be accessible on the Events page of the Investors section of the Novan website, www.novan.com, for 90 days following the events.

About Novan

Novan, Inc. is a specialty dermatology company focused on researching, developing and marketing innovative therapeutic products for skin diseases. Through our acquisition of EPI Health, we sell products for acne, rosacea, dermatosis, and psoriasis. Our goal is to deliver safe and efficacious therapies where there are unmet medical needs. We are developing SB206 (berdazimer gel 10.3%) as a topical prescription gel for the treatment of viral skin infections, with a current focus on molluscum contagiosum. We have a pipeline of product candidates using our proprietary nitric oxide-based technology platform, NITRICIL™, to generate new treatments for multiple indications.

INVESTOR AND MEDIA CONTACT:

Jenene Thomas
JTC Team, LLC
833-475-8247
NOVN@jtcir.com


FAQ

When is Novan's CEO presenting at the Roth Conference?

Paula Brown Stafford will present at the 34th Annual Roth Conference on March 14, 2022, at 3:30 PM ET.

What event will Novan participate in on March 16, 2022?

Novan will participate in the Oppenheimer 32nd Annual Healthcare Conference with a virtual presentation on March 16, 2022, at 1:20 PM ET.

How can I access Novan's conference presentations?

Webcasts of the fireside chat and presentation will be available on Novan's website for 90 days following the events.

What is Novan's focus in dermatology?

Novan focuses on researching and developing innovative therapeutic products for skin diseases, including acne, rosacea, and viral skin infections.

What is the ticker symbol for Novan, Inc.?

The ticker symbol for Novan, Inc. is NOVN.

NOVN

NASDAQ:NOVN

NOVN Rankings

NOVN Latest News

NOVN Stock Data

2.64M
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
US
Morrisville